← Eichor
Study identifier: NCT07046364 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Remimazolam and Emergence Delirium in Pediatrics

Condition: Pediatric · Neurosurgery · Sevoflurane Anesthesia  ·  Sponsor: Peking University First Hospital

PhasePhase 4
Planned participants248
Who can joinAll sexes, 1 Year to 6 Years
Healthy volunteersNo

About this study

Emergence delirium is a common complication in pediatrics undergoing neurosurgery. Previous study showed that a single bolus of remimazolam was associated with lower incidence of postoperative agitation. Present study was designed to investigate if remimazolam supplemented to sevoflurane anesthesia could decrease the risk of emergence delirium in pediatrics undergoing neurosurgery.

This description comes directly from the study's public registry record.

Talk to the study team

Dong-liang Mu  ·  +86 010 83575138  ·  mudongliang@bjmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (2)

Peking University First HospitalBeijing, Beijing Municipality, ChinaNot Yet Recruiting
Peking University First HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07046364